Publicaciones (24) Publicaciones en las que ha participado algún/a investigador/a

2020

  1. Addressing maladaptive interpersonal schemas, poor metacognition and maladaptive coping strategies in Avoidant Personality Disorder: The role of experiential techniques

    Psychology Hub, Vol. 37, Núm. 1, pp. 19-28

  2. Atención en los servicios de urgencias

    Manual de trastornos adictivos (J. Belarmino Bobes, M. Casas y M. Gutiérrez), pp. 345-356

  3. Beyond Clinical High-Risk State for Psychosis: The Network Structure of Multidimensional Psychosis Liability in Adolescents

    Frontiers in Psychiatry, Vol. 10

  4. Brain White Matter Correlates of Creativity in Schizophrenia: A Diffusion Tensor Imaging Study

    Frontiers in Neuroscience, Vol. 14

  5. Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection?

    European Journal of Epidemiology

  6. Drug pollution and pharmacotherapy in psychiatry: A "platypus" in the room

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 63, Núm. 1, pp. e33

  7. Early SARS-CoV-2 outbreak detection by sewage-based epidemiology

    Science of the Total Environment, Vol. 732

  8. Effect of paliperidone palmitate 3-month formulation on goal attainment and disability after 52 weeks’ treatment in patients with clinically stable schizophrenia

    Neuropsychiatric Disease and Treatment, Vol. 16, pp. 3197-3208

  9. Effect of psychiatric symptoms and quality of life on cognitive performance in HCV patients

    Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 1, pp. 22-30

  10. Experiencias psicóticas atenuadas y consumo de cannabis en adolescentes de la población general

    Adicciones: Revista de socidrogalcohol, Vol. 32, Núm. 1, pp. 41-51

  11. Farmakokutsadura: medikamentuak ere naturaren kutsatzaile?!

    Elhuyar: zientzia eta teknika, Núm. 339, pp. 80-85

  12. It's about time healthcare professionals and academics start thinking about drug pollution

    Sustainable Chemistry and Pharmacy

  13. La psicología clínica ante la pandemia COVID-19 en España

    Clínica y salud: Investigación Empírica en Psicología, Vol. 31, Núm. 2, pp. 105-107

  14. Mass drug administration: time to consider drug pollution?

    The Lancet

  15. Mediating role of cognition and social cognition on creativity among patients with schizophrenia and healthy controls: Revisiting the Shared Vulnerability Model

    Psychiatry and Clinical Neurosciences, Vol. 74, Núm. 2, pp. 149-155

  16. Metacognitive Interpersonal Therapy in Group for Personality Disorders: Preliminary Results from a Pilot Study in a Public Mental Health Setting

    Journal of Contemporary Psychotherapy, Vol. 50, Núm. 3, pp. 197-203

  17. Modelos etiológicos en problemas de salud mental

    Desafíos y oportunidades para el desarrollo y la atención integral de adolescente: propuestas multidisciplinares en entornos globales (Wolters Kluwer España), pp. 53-67

  18. Neurocognitive, social cognitive, and clinical predictors of creativity in schizophrenia

    Journal of Psychiatric Research, Vol. 129, pp. 206-213

  19. Psychological Intervention and COVID-19: What We Know So Far and What We Can Do

    Journal of Contemporary Psychotherapy, Vol. 50, Núm. 4, pp. 243-250

  20. Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene

    Schizophrenia Research